<DOC>
	<DOCNO>NCT00539149</DOCNO>
	<brief_summary>This clinical trial conduct population tympanic membrane perforation occur 60 % infant first year life . Nasopharyngeal colonisation ( nasal contamination ) pathogenic bacteria occur within week life predict persistent middle ear infection throughout childhood . The trial aim assess whether twice daily antibiotic commence first detection middle ear effusion would cure infection and/or prevent disease progression , compare placebo . The study conduct three remote Aboriginal community Northern Territory Australia . The annual birth cohort 45 . Aboriginal infant see soon possible birth , 2 weekly interval middle ear effusion detect pneumatic otoscopy tympanometry . Following consent , infant randomise either amoxycillin ( 50 mg/kg/d BD ) placebo equivalent 24 week , normal middle ear status detect 2 consecutive monthly schedule examination . At monthly examination infant also general health check , parent interview , child 's medical record review , nasopharyngeal swab collect .</brief_summary>
	<brief_title>Long-term Antibiotics Treatment Prevention Otitis Media Aborignal Children</brief_title>
	<detailed_description />
	<mesh_term>Otitis</mesh_term>
	<mesh_term>Otitis Media</mesh_term>
	<mesh_term>Otitis Media Effusion</mesh_term>
	<mesh_term>Amoxicillin</mesh_term>
	<criteria>Australian Aboriginal Living participate remote community Less 12 month age Less 32 week gestation Chronic condition require continuous antibiotic Ear , nose throat abnormality</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>12 Months</maximum_age>
	<verification_date>October 2007</verification_date>
	<keyword>Acute otitis medium</keyword>
	<keyword>Otitis medium effusion</keyword>
	<keyword>Tympanic membrane perforation</keyword>
</DOC>